Ozempic warning: 21 year-old woman develops deadly blood complication after taking Mounjaro for just three weeks

An unnamed patient in Kuwait, 21, went into ketoacidosis after three weeks of taking tirzepatide, the active ingredient in blockbuster weight loss drugs Mounjaro and Zepbound.An unnamed patient in Kuwait, 21, went into ketoacidosis after three weeks of taking tirzepatide, the active ingredient in blockbuster weight loss drugs Mounjaro and Zepbound.Read MoreHealth News | Mail Online